CX-908

DEVELOPMENT STEP preclinical
SPONSOR MATRIX CytomX Therapeutics [CTMX]
MECHANISM TARGET // UNMAPPED_TARGET

[THERAPEUTIC_PROFILE]

Target Indications

Solid Tumors

Mechanism Abstract

CX-908 is a PROBODY® T Cell Engager Targeting CDH3 and CD3

[CLINICAL_TRIALS_REGISTRY]

// NO_ACTIVE_REGISTRY_STUDIES_FOUND (CX-908)